Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | BMY | AMGN | GILD | REGN |
| Company | Akcea Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.15 | 70.32 | 243.78 | 82.37 | 749.20 |
| High | 18.17 | 72.61 | 243.78 | 82.50 | 758.72 |
| Low | 18.13 | 69.80 | 236.37 | 80.60 | 741.45 |
| Last | 18.17 | 72.11 | 239.38 | 81.10 | 754.00 |
| Change | +0.03 | +0.88 | -7.03 | -2.90 | -4.00 |
| % Change | +0.17% | +1.24% | -2.85% | -3.45% | -0.53% |
| Volume | 815,300 | 5,810,534 | 2,478,853 | 5,330,463 | 432,491 |
| 20-Day Average Volume | 661,490 | 8,171,081 | 2,337,332 | 6,306,245 | 630,603 |
| Previous Close | 18.14 | 71.23 | 246.41 | 84.00 | 758.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 72.42 | 261.85 | 84.61 | 728.37 |
| 20-Day Raw Stochastic | 70.59% | 48.85% | 9.34% | 6.89% | 90.95% |
| 20-Day Relative Strength | 73.10% | 45.90% | 27.23% | 40.28% | 56.71% |
| Weighted Alpha | -23.90 | +6.01 | +1.93 | +31.19 | +18.05 |
| Today's Opinion | 72% Buy | 56% Sell | 8% Sell | 40% Buy | 64% Buy |
| Previous Opinion | 64% Buy | 56% Sell | 8% Sell | 40% Buy | 64% Buy |
| Last Month's Opinion | 8% Buy | 24% Sell | 40% Buy | 80% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | -0.89% since 01/26/23 | -5.78% since 01/26/23 | -2.98% since 01/26/23 | +1.52% since 01/26/23 |
| Low | 18.08 on 10/05/20 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.60 on 02/02/23 | 732.49 on 01/30/23 |
| High | 18.17 on 10/09/20 | 73.45 on 01/27/23 | 255.50 on 01/27/23 | 84.65 on 02/01/23 | 762.09 on 02/01/23 |
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | +0.54% since 12/30/22 | -8.56% since 12/30/22 | -5.50% since 12/30/22 | +4.45% since 12/30/22 |
| Low | 18.05 on 09/21/20 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.60 on 02/02/23 | 668.00 on 01/09/23 |
| High | 18.22 on 09/28/20 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 762.09 on 02/01/23 |
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -6.60% since 11/02/22 | -10.73% since 11/02/22 | +4.17% since 11/02/22 | +1.77% since 11/02/22 |
| Low | 9.81 on 08/05/20 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 77.16 on 11/03/22 | 668.00 on 01/09/23 |
| High | 19.65 on 08/31/20 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 779.00 on 12/08/22 |
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | -1.28% since 08/02/22 | -1.54% since 08/02/22 | +36.26% since 08/02/22 | +31.07% since 08/02/22 |
| Low | 9.81 on 08/05/20 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 60.62 on 08/05/22 | 572.22 on 09/06/22 |
| High | 19.65 on 08/31/20 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 779.00 on 12/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 151,446,384 | 131,479,200 | 105,356,496 | 82,547,712 |
| Shares Outstanding, K | 101,599 | 2,126,160 | 533,579 | 1,254,244 | 108,902 |
| Annual Sales | 488,540,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | 40,770,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 22,380,000 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,936,200,000 |
| Last Quarter Net Income | -49,580,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 1,315,700,000 |
| 60-Month Beta | 1.45 | 0.43 | 0.64 | 0.39 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | 1.99 on 10/25/22 | 4.09 on 01/31/23 | 1.90 on 10/27/22 | 11.14 on 11/03/22 |
| Latest Earnings Date | 11/03/20 | 02/02/23 | 01/31/23 | 02/02/23 | 02/03/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.42 | 14.27 | 13.35 | 13.80 |
